Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents

Molecular Pharmaceutics

Volumn 8, Issue 3, 2011, Pages 748-757

  Sanna, Vanna ^a   Pintus, Gianfranco ^b   Bandiera, Pasquale ^b   Anedda, Roberto ^a   Punzoni, Stefania ^b   Sanna, Bastiano ^b   Migaleddu, Vincenzo ^c   Uzzau, Sergio ^a,b   Sechi, Mario ^b  

^a Porto Conte Ricerche Srl   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Sardinian Mediterranean Imaging Research Group no Profit Foundation   (Italy)

Author keywords

biodegradable polymers; contrast agents; prostate cancer; prostate specific membrane antigen (PSMA); targeted microbubbles; ultrasound

Indexed keywords

MACROGOL; POLYGLACTIN; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ECHOGRAPHY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBUBBLE; PRIORITY JOURNAL;

ANTIGENS, SURFACE; CELL LINE, TUMOR; CONTRAST MEDIA; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; MICROBUBBLES; POLYMERS; PROSTATIC NEOPLASMS;

EID: 79958268945     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100360g     Document Type: Article

References (59)

1. Willmann, J. K.; van Bruggen, N.; Dinkelborg, L. M.; Gambhir, S. S. Molecular imaging in drug development Nat. Rev. Drug Discovery 2008, 7, 591-607 (Pubitemid 351927724)
2. Rapoport, N.; Kennedy, A. M.; Shea, J. E.; Scaife, C. L.; Nam, K. H. Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging Mol. Pharmaceutics 2010, 7, 22-31
3. Lindner, J. R. Microbubbles in medical imaging: current applications and future directions Nat. Rev. Drug Discovery 2004, 3, 527-532 (Pubitemid 38807535)
4. Cosgrove, D. Ultrasound contrast agents: an overview Eur. J. Radiol. 2006, 60, 324-330
5. Hernot, S.; Klibanov, A. L. Microbubbles in ultrasound-triggered drug and gene delivery Adv. Drug Delivery Rev. 2008, 60, 1153-1166
6. Cavalieri, F.; Ashokkumar, M.; Grieser, F.; Caruso, F. Ultrasonic Synthesis of Stable, Functional Lysozyme Microbubbles Langmuir 2008, 24, 10078-10083
7. Xing, Z.; Ke, H.; Wang, J.; Zhao, B.; Yue, X.; Dai, Z.; Liu, J. Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate Acta Biomater. 2010, 6, 3542-3549
8. Barnhart, J.; Levene, H.; Villapando, E.; Maniquis, J.; Fernandez, J.; Rice, S.; Jablonski, E.; Gjøen, T.; Tolleshaug, H. Characteristics of Albunex: air-filled albumin microspheres for echocardiography contrast enhancement Invest. Radiol. 1990, 25 (Suppl. 1) S162-164
9. Ferrara, K. W.; Borden, M. A.; Zhang, H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery Acc. Chem. Res. 2009, 42, 881-892
10. El-Sherif, D. M.; Wheatley, M. A. Development of a novel method for synthesis of a polymeric ultrasound contrast agent J. Biomed. Mater. Res. A 2003, 66, 347-355 (Pubitemid 37517235)
11. Krupka, T. M.; Solorio, L.; Wilson, R. E.; Wu, H.; Azar, N.; Exner, A. A. Formulation and Characterization of Echogenic Lipid-Pluronic Nanobubbles Mol. Pharmaceutics 2010, 7, 49-59
12. Sakamoto, J. H.; Smith, B. R.; Xie, B.; Rokhlin, S. I.; Lee, S. C.; Ferrari, M. The molecular analysis of breast cancer utilizing targeted nanoparticle based ultrasound contrast agents Technol. Cancer Res. Treat. 2005, 4, 627-636 (Pubitemid 43083346)
13. Quaia, E. Microbubble ultrasound contrast agent: an update Eur. J. Radiol. 2007, 17, 1995-2008 (Pubitemid 47097457)
14. Pillai, R.; Marinelli, E. R.; Fan, H.; Nanjappan, P.; Song, B.; von Wronski, M. A.; Cherkaoui, S.; Tardy, I.; Pochon, S.; Schneider, M.; Nunn, A. D.; Swenson, R. E. A Phospholipid-PEG2000 Conjugate of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeting Heterodimer Peptide for Contrast-Enhanced Ultrasound Imaging of Angiogenesis Bioconjugate Chem. 2010, 21, 556-562
15. Korpanty, G.; Grayburn, P. A.; Shohet, R. V.; Brekken, R. A. Targeting vascular endothelium with avidin microbubbles Ultrasound Med. Biol. 2005, 31, 1279-1283 (Pubitemid 41318861)
16. Weller, G. E.; Wong, M. K.; Modzelewski, R. A.; Lu, E.; Klibanov, A. L.; Wagner, W. R.; Villanueva, F. S. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginineleucine Cancer Res. 2005, 65, 533-539
17. Lindner, J. R. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography Nat. Rev. Cardiol. 2009, 6, 475-481
18. Kim, D. H.; Klibanov, A. L.; Needham, D. The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptor-ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated glass beads Langmuir 2000, 16, 2808-2817 (Pubitemid 30576809)
19. Mayer, C. R.; Bekeredjian, R. Ultrasonic gene and drug delivery to the cardiovascular system Adv. Drug Delivery Rev. 2008, 60, 1177-1192
20. Böhmer, M. R.; Klibanov, A. L.; Tiemann, K.; Hall, C. S.; Gruell, H.; Steinbach, O. C. Ultrasound triggered image-guided drug delivery Eur. J. Radiol. 2009, 70, 242-253
21. Willmann, J. K.; Cheng, Z.; Davis, C.; Lutz, A. M.; Schipper, M. L.; Nielsen, C. H.; Gambhir, S. S. Targeted Microbubbles for Imaging Tumor Angiogenesis: Assessment of Whole-Body Biodistribution with Dynamic Micro-PET in Mice Radiology 2008, 249, 212-219
22. Reinhardt, M.; Hauff, P.; Linker, R. A.; Briel, A.; Gold, R.; Rieckmann, P.; Becker, G.; Toyka, K. V.; Mäurer, M.; Schirner, M. Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by sensitive particle acoustic quantification (SPAQ) Neuroimage 2005, 27, 267-278 (Pubitemid 41074830)
23. Schumann, P. A.; Christiansen, J. P.; Quigley, R. M.; McCreery, T. P.; Sweitzer, R. H.; Unger, E. C.; Lindner, J. R.; Matsunaga, T. O. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi Invest. Radiol. 2002, 37, 587-593 (Pubitemid 35231692)
24. Lindner, J. R.; Dayton, P. A.; Coggins, M. P.; Ley, K.; Song, J.; Ferrara, K.; Kaul, S. Non-invasive assessment of inflammation using ultrasound detection of phagocytosed microbubbles Circulation 2000, 102, 531-538 (Pubitemid 30639971)
25. Chappell, J. C.; Price, R,J. Targeted therapeutic applications of acoustically active microspheres in the microcirculation Microcirculation 2006, 13, 57-70 (Pubitemid 43050891)
26. Bloch, S. H.; Dayton, P.; Ferrara, K. W. Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications IEEE Eng. Med. Biol. Mag. 2004, 23, 18-29
27. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics 2008 Ca-Cancer J. Clin. 2008, 58, 71-96
28. Kularatne, S. A.; Wang, K.; Santhapuram, H. K. R.; Low, P. S. Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand Mol. Pharmaceutics 2009, 6, 780-789
29. Rajasekaran, A. K.; Anilkumar, G.; Christiansen, J. J. Is prostate-specific membrane antigen a multifunctional protein? Am. J. Physiol. 2005, 288, C975-981
30. Ghosh, A.; Heston, W. D. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer J. Cell. Biochem. 2004, 91, 528-539
31. Chang, S. S.; O'Keefe, D. S.; Bacich, D. J.; Reuter, V. E.; Heston, W. D.; Gaudin, P. B. Prostate-specific membrane antigen is produced in tumor-associated neovasculature Clin. Cancer Res. 1999, 5, 2674-2681 (Pubitemid 29493938)
32. Colombatti, M.; Grasso, S.; Porzia, A.; Fracasso, G.; Scupoli, M. T.; Cingarlini, S.; Poffe, O.; Naim, H. Y.; Heine, M.; Tridente, G.; Mainiero, F.; Ramarli, D. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways PLoS One 2009, 4, e4608
33. Wolf, P.; Freudenberg, N.; Bühler, P.; Alt, K.; Schultze-Seemann, W.; Wetterauer, U.; Elsässer-Beile, U. Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer Prostate 2010, 70, 562-569
34. Elsässer-Beile, U.; Bühler, P.; Wolf, P. Targeted therapies for prostate cancer against the prostate specific membrane antigen Curr. Drug Targets 2009, 10, 118-125
35. Apolo, A. B.; Pandit-Taskar, N.; Morris, M. J. Novel tracers and their development for the imaging of metastatic prostate cancer J. Nucl. Med. 2008, 49, 2031-2041
36. Troyer, J. K.; Beckett, M. L.; Wright, G. L., Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids Int. J. Cancer 1995, 62, 552-558
37. Nargund, V.; Al Hashmi, D.; Kumar, P.; Gordon, S.; Otitie, U.; Ellison, D.; Carroll, M.; Baithun, S.; Britton, K. E. Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological staging BJU Int. 2005, 95, 1232-1236 (Pubitemid 40799436)
38. Bouchelouche, K.; Capala, J.; Oehr, P. Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer Curr. Opin. Oncol. 2009, 21, 469-474
39. Milowsky, M. I.; Nanus, D. M.; Kostakoglu, L. Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors J. Clin. Oncol. 2007, 25, 540-547 (Pubitemid 350002961)
40. Byun, Y.; Mease, R. C.; Lupold, S. E.; Pomper, M. G. In Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications; Supuran, C. T.; Winum, J.-Y., Eds.; Binghe Wang Wiley Series in Drug Discovery and Development; John Wiley and Sons: Hoboken, NJ, 2009; pp 881-910.
41. Zhou, J.; Neale, J. H.; Pomper, M. G.; Kozikowski, A. P. NAAG peptidase inhibitors and their potential for diagnosis and therapy Nat. Rev. Drug Discovery 2005, 4, 1015-1026
42. Maresca, K. P.; Hillier, S. M.; Femia, F. J.; Keith, D.; Barone, C.; Joyal, J. L.; Zimmerman, C. N.; Kozikowski, A. P.; Barrett, J. A.; Eckelman, W. C. A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer J. Med. Chem. 2009, 52, 347-357
43. Sanna, V.; Pintus, G.; Roggio, A. M.; Punzoni, S.; Posadino, A. M.; Arca, A.; Marceddu, S.; Bandiera, P.; Uzzau, S.; Sechi, M. Targeted Biocompatible Nanoparticles for the Delivery of (-)-Epigallocatechin 3-Gallate to Prostate Cancer Cells J. Med. Chem. 2011, 54, 1321-1332
44. Yang, F.; Gu, A.; Chen, Z.; Gu, N.; Ji, M. Multiple emulsion microbubbles for ultrasound imaging Mater. Lett. 2008, 62, 121-124 (Pubitemid 350100950)
45. Yang, F.; Li, Y.; Chen, Z.; Zhang, Y.; Wu, J.; Gu, N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging Biomaterials 2009, 30, 3882-3890
46. Pasciu, V.; Posadino, A. M.; Cossu, A.; Sanna, B.; Tadolini, B.; Gaspa, L.; Marchisio, A.; Dessole, S.; Capobianco, G.; Pintus, G. Akt downregulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants Toxicol. Sci. 2010, 114, 101-112
47. Avgoustakis, K. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr. Drug Delivery 2004, 1, 321-333
48. Gref, R.; Luck, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Muller, R. H. Stealth" corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf., B 2000, 18, 301-313 (Pubitemid 30479870)
49. Schülke, N.; Varlamova, O. A.; Donovan, G. P.; Ma, D.; Gardner, J. P.; Morrissey, D. M.; Arrigale, R. R.; Zhan, C.; Chodera, A. J.; Surowitz, K. G.; Maddon, P. J.; Heston, W. D.; Olson, W. C. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 12590-12595 (Pubitemid 37339943)
50. Mesters, J. R.; Barinka, C.; Li, W.; Tsukamoto, T.; Majer, P.; Slusher, B. S.; Konvalinka, J.; Hilgenfeld, R. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer EMBO J. 2006, 25, 1375-1384
51. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2586-2591 (Pubitemid 351520557)
52. Betancourt, T.; Byrne, J. D.; Sunaryo, N.; Crowder, S. W.; Kadapakkam, M.; Patel, S.; Casciato, S.; Brannon-Peppas, L. PEGylation strategies for active targeting of PLA/PLGA nanoparticles J. Biomed. Mater. Res. A. 2009, 91, 263-276
53. El-Sherif, D. M.; Lathia, J. D.; Le, N. T.; Wheatley, M. A. Ultrasound degradation of novel polymer contrast agents J. Biomed. Mater. Res. A. 2004, 68, 71-78 (Pubitemid 38030186)
54. Rosca, I. D.; Watari, F.; Uo, M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation J. Controlled Release 2004, 99, 271-280 (Pubitemid 39222112)
55. Morgan, K. E.; Allen, J. S.; Dayton, P. A.; Chomas, J. E.; Klibanov, A. L.; Ferrara, K. W. Experimental and theoretical evaluation of microbubble behavior: Effect of transmitted phase and bubble size IEEE Trans. Ultrason., Ferroelectr. Freq. Control 2000, 47, 1494-1509 (Pubitemid 32076218)
56. Banerjee, S. R.; Foss, A. C.; Castanares, M.; Mease, R. C.; Byun, Y.; Fox, J. J.; Hilton, J.; Lupold, S. E.; Kozikowski, A. P.; Pomper, M. G. Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) J. Med. Chem. 2008, 51, 4504-4517
57. Maclaren, J. A. Some amino acid esters-an improved preparative method Aust. J. Chem. 1978, 31, 1865-1868
58. Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X.; Levy-Nissenbaum, E.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 2007, 28, 869-876 (Pubitemid 44667020)
59. Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C.; Lippard, S. J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 17356-17361